Range
- - -
Vol / Avg.
1K/1M
Div / Yield
-
52 Wk
4.95 - 10.09
Mkt Cap
479.5M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.19
Shares
78.1M
Outstanding
78.1M
Total Float
66.4M
Benzinga - 3 days ago
Benzinga - 4 days ago
Benzinga - May 25, 2021, 7:01AM
Benzinga - Apr 28, 2021, 4:33PM
Benzinga - Feb 17, 2021, 4:16PM
Benzinga - Jan 6, 2021, 4:08PM
Benzinga - Oct 29, 2020, 11:57AM
Benzinga - Oct 29, 2020, 8:54AM
Benzinga - Oct 28, 2020, 4:12PM
Benzinga - Sep 9, 2020, 7:10AM
load more
Sector: Health Care.Industry: Biotechnology
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-07-28
REV
Q1 2021Est.ActualSurprise
EPS-0.170-0.190 -0.0200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
VKTXViking Therapeutics0.16%479.5M

Viking Therapeutics Frequently Asked Questions

Q

How do I buy Viking Therapeutics (VKTX) stock?

A

You can purchase shares of Viking Therapeutics (NASDAQ: VKTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Viking Therapeutics's (VKTX) competitors?

A

Other companies in Viking Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), CytomX Therapeutics (NASDAQ:CTMX), OncoCyte (NASDAQ:OCX), Gritstone Bio (NASDAQ:GRTS) and Harpoon Therapeutics (NASDAQ:HARP).

Q

What is the target price for Viking Therapeutics (VKTX) stock?

A

The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by Raymond James on May 25, 2021. The analyst firm set a price target for 12.00 expecting VKTX to rise to within 12 months (a possible 95.44% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Viking Therapeutics (VKTX)?

A

The stock price for Viking Therapeutics (NASDAQ: VKTX) is $6.14 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Viking Therapeutics (VKTX) pay a dividend?

A

There are no upcoming dividends for Viking Therapeutics.

Q

When is Viking Therapeutics (NASDAQ:VKTX) reporting earnings?

A
Viking Therapeutics’s Q2 earnings are confirmed for after-market on July 28, 2021.
Q

Is Viking Therapeutics (VKTX) going to split?

A

There is no upcoming split for Viking Therapeutics.

Q

What sector and industry does Viking Therapeutics (VKTX) operate in?

A

Viking Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.